These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22490617)

  • 21. Frequencies of Anti-Troponin I vs Anti-Troponin T Autoantibodies and Degrees of Interference on Troponin Assays.
    Nakano K; Sugawa S; Seimiya M; Murakami S; Yasuda K; Watanabe C; Goto H; Teshima T
    Lab Med; 2023 May; 54(3):317-323. PubMed ID: 36322014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines.
    Ylänen K; Poutanen T; Savukoski T; Eerola A; Vettenranta K
    Acta Paediatr; 2015 Mar; 104(3):313-9. PubMed ID: 25393922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I.
    Newman DJ; Olabiran Y; Bedzyk WD; Chance S; Gorman EG; Price CP
    Clin Chem; 1999 Jun; 45(6 Pt 1):822-8. PubMed ID: 10351991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous alkaline phosphatase interference in cardiac troponin I and other sensitive chemiluminescence immunoassays that use alkaline phosphatase activity for signal amplification.
    Herman DS; Ranjitkar P; Yamaguchi D; Grenache DG; Greene DN
    Clin Biochem; 2016 Oct; 49(15):1118-1121. PubMed ID: 27317886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of elevated concentration of alkaline phosphatase on cardiac troponin I assays.
    Dasgupta A; Chow L; Wells A; Datta P
    J Clin Lab Anal; 2001; 15(4):175-7. PubMed ID: 11436198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    Circulation; 2007 Oct; 116(17):1907-14. PubMed ID: 17909103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays.
    Shi Q; Ling M; Zhang X; Zhang M; Kadijevic L; Liu S; Laurino JP
    Clin Chem; 1999 Jul; 45(7):1018-25. PubMed ID: 10388478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies.
    Kim WJ; Laterza OF; Hock KG; Pierson-Perry JF; Kaminski DM; Mesguich M; Braconnier F; Zimmermann R; Zaninotto M; Plebani M; Hanna A; Cembrowski GS; Scott MG
    Clin Chem; 2002 Jul; 48(7):1028-34. PubMed ID: 12089171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of high-sensitivity troponin I versus troponin T in acute coronary syndromes.
    Correia LC; Sodré FL; Lima JC; Sabino M; Brito M; Garcia G; Maraux M; Sousa AC; Noya-Rabelo M; Esteves JP
    Arq Bras Cardiol; 2012 May; 98(5):406-12. PubMed ID: 22481641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality specifications for biochemical markers of myocardial injury.
    Zaninotto M; Mion M; Altinier S; Forni M; Plebani M
    Clin Chim Acta; 2004 Aug; 346(1):65-72. PubMed ID: 15234637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project.
    Tate JR; Bunk DM; Christenson RH; Barth JH; Katrukha A; Noble JE; Schimmel H; Wang L; Panteghini M;
    Clin Chem Lab Med; 2015 Apr; 53(5):677-90. PubMed ID: 25999287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population.
    Apple FS; Ler R; Murakami MM
    Clin Chem; 2012 Nov; 58(11):1574-81. PubMed ID: 22983113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple immunoassay systems are negatively interfered by circulating cardiac troponin I autoantibodies.
    Tang G; Wu Y; Zhao W; Shen Q
    Clin Exp Med; 2012 Mar; 12(1):47-53. PubMed ID: 21655961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
    Venge P; Johnston N; Lindahl B; James S
    J Am Coll Cardiol; 2009 Sep; 54(13):1165-72. PubMed ID: 19761938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36.
    Bonaca MP; O'Malley RG; Murphy SA; Jarolim P; Conrad MJ; Braunwald E; Sabatine MS; Morrow DA
    Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):431-40. PubMed ID: 25538086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upconverting nanophosphors as reporters in a highly sensitive heterogeneous immunoassay for cardiac troponin I.
    Sirkka N; Lyytikäinen A; Savukoski T; Soukka T
    Anal Chim Acta; 2016 Jun; 925():82-7. PubMed ID: 27188320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system.
    Storti S; Prontera C; Parri MS; Iervasi A; Vittorini S; Emdin M; Zucchelli GC; Longombardo G; Migliorini P; Clerico A
    Clin Chem Lab Med; 2006; 44(8):1022-9. PubMed ID: 16879072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac troponin I, cardiac troponin-specific autoantibodies and natriuretic peptides in children with hypoplastic left heart syndrome.
    Eerola A; Poutanen T; Savukoski T; Pettersson K; Sairanen H; Jokinen E; Pihkala J
    Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):80-5. PubMed ID: 24101702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of analytical performance of the Pathfast cardiac troponin I.
    Di Serio F; Caputo M; Zaninotto M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2009; 47(7):829-33. PubMed ID: 19453290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.